Related Experiment Video

Updated: Apr 26, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

23.7K

Epidemiology and natural history of hepatitis C virus infection

Mei-Hsuan Lee1, Hwai-I Yang1, Yong Yuan1

  • 1Mei-Hsuan Lee, the Institute of Clinical Medicine, National Yang-Ming University, Taipei 155, Taiwan.

World Journal of Gastroenterology
|July 30, 2014
PubMed

Insights

Hepatitis C virus (HCV) infection is a major cause of liver cancer. The REVEAL-HCV study tracked over 1000 individuals for 15 years, offering unique insights into HCV

Area of Science:

  • Hepatology
  • Virology
  • Epidemiology

Background:

  • Hepatitis C virus (HCV) infection impacts 130-210 million globally, significantly increasing hepatocellular carcinoma risk.
  • HCV is linked to at least one-third of liver cancer cases and causes 350,000 deaths annually.
  • Geographical variations in HCV prevalence and risk factors necessitate localized research.

Purpose of the Study:

  • To elucidate the natural history of HCV-associated hepatocellular carcinoma.
  • To identify potential seromarkers for predicting liver cancer risk in HCV patients.
  • To analyze the progression of chronic hepatitis C to end-stage liver disease.

Main Methods:

  • The REVEAL-HCV study prospectively followed 1095 Taiwanese residents with HCV antibodies for over 15 years.
  • Participants acquired HCV primarily through iatrogenic transmission.
  • Limited antiviral therapy use in the cohort allows for natural history observation.

Main Results:

  • The review comprehensively examines HCV prevalence, risk factors, and natural history.
  • Liver disease progression in the REVEAL-HCV cohort is detailed.
  • Findings contribute to understanding HCV's long-term impact.

Conclusions:

  • Prospective cohorts like REVEAL-HCV are crucial for understanding HCV natural history and liver cancer development.
  • The study provides valuable data on HCV progression in a population with limited treatment.
  • Further research can leverage these findings to develop better risk prediction and prevention strategies.

Keywords:
EpidemiologyHepatitis C virusLong-term liver progressionRisk evaluation of viral load elevation and associated liver disease/cancer

More Related Videos

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

5.5K
A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

9.4K

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
78
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
21
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
96
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
33
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
42.8K
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
25